← All companies

RLAY — Relay Therapeutics, Inc.

Materials · Biological Products, (No Diagnostic Substances) · Nasdaq

CIK 0001812364 · FYE 1231 · All Form 4 filings on EDGAR ↗

4Insiders filing

2Transactions

+$0Reported buys

−$116.5MReported sells

1Cluster events

Window in data: 2026-08-25 → 2026-08-26 · Data as of 2026-08-31

Cluster membership

Week	Window	Tier	Dir	Insiders	Total value
2026-W35	2026-08-25 → 2026-08-26	WATCH	− sell	4	$116.5M

Insiders

Insider	Role	Txns	Reported value
SB INVESTMENT ADVISERS (UK) LTD	10% Owner	1	$116.4M
SOFTBANK VISION FUND (AIV M2) L.P.	10% Owner	1	$116.4M
SVF Pauling (Cayman) Ltd	10% Owner	1	$116.4M
Rahmer Peter	See remarks	1	$90k

Transaction history

Filing date	Trade date	Ticker	Insider	Type	Shares	Price	Value	Cluster
2026-08-28	2026-08-26	RLAY	Rahmer Peter See remarks 10b5-1	S	4,508	$20.03	−$90k	✓ Cluster clu-141d0baf0df1
2026-08-28	2026-08-25	RLAY	SB INVESTMENT ADVISERS (UK) LTD 10% Owner	S	6,000,000	$19.40	−$116.4M	✓ Cluster clu-141d0baf0df1

Known data limitations

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Insider Atlas is a descriptive research site, not investment advice — see the methodology for the full provenance chain.